000 01344 a2200373 4500
005 20250515011336.0
264 0 _c20070613
008 200706s 0 0 eng d
022 _a1471-4892
024 7 _a10.1016/j.coph.2005.10.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBowery, Norman G
245 0 0 _aGABAB receptor: a site of therapeutic benefit.
_h[electronic resource]
260 _bCurrent opinion in pharmacology
_cFeb 2006
300 _a37-43 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBaclofen
_xpharmacology
650 0 4 _aBrain
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aCognition
_xdrug effects
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aEpilepsy, Absence
_xdrug therapy
650 0 4 _aGABA Agonists
_xpharmacology
650 0 4 _aGABA Antagonists
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMuscle Spasticity
_xdrug therapy
650 0 4 _aOrganophosphorus Compounds
_xpharmacology
650 0 4 _aPain
_xdrug therapy
650 0 4 _aReceptors, GABA-B
_xclassification
650 0 4 _aSubstance-Related Disorders
_xdrug therapy
773 0 _tCurrent opinion in pharmacology
_gvol. 6
_gno. 1
_gp. 37-43
856 4 0 _uhttps://doi.org/10.1016/j.coph.2005.10.002
_zAvailable from publisher's website
999 _c15981125
_d15981125